Clinique Alpa | Alpa Care LtdClinical policy
PRP pre-treatment screening policy
This policy sets out the clinical assessment and safety requirements before platelet-rich plasma (PRP) treatment at Clinique Alpa. It supports an individual, documented decision about whether treatment is appropriate.
- Policy reference
- CA-CLIN-SOP-PRP-001
- Version
- 1.0 · Final
- Approved by
- Dr Mitesh Parmar
- Approval date
- Review due
PDF document · Version 1.0
Assessment before treatment
The policy requires a clinician-led medical and medication history, examination of the proposed treatment site, relevant investigations and specialist advice where indicated. A decision must be documented before each treatment. Booking or requesting PRP does not establish suitability.
Conditions that need particular consideration
Screening explicitly addresses HIV/AIDS, blood malignancy, local skin cancer, hepatitis C, cardiovascular disease, and anticoagulant or antiplatelet treatment, alongside broader contraindications and precautions.
- Treatment must be deferred where active treatment-site infection, acute systemic illness, suspected local cancer, unstable disease, significant bleeding risk or another unresolved safety concern is present.
- Controlled or previously treated disease is assessed individually. A diagnostic label alone is not an automatic permanent exclusion.
- Necessary blood-thinning medication must not be stopped routinely to enable PRP. Any proposed change requires assessment and agreement from the responsible prescriber.
Consent, safety and accountability
The full policy distinguishes absolute treatment stops from relative precautions and specifies informed consent, infection prevention, product traceability, escalation, documentation, staff responsibilities, audit and document review. The full document contains the detailed criteria and references; this page is a summary.
The policy sets the required standard. Its publication does not itself establish that an individual is suitable for treatment.
For questions about the policy or an accessible format, please contact the clinic. Read more about clinical governance at Clinique Alpa.